文献速递区域麻醉与超声疼痛医学

全膝关节置换术后多模式镇痛方案中添加右美托咪定、氯胺酮、地塞米松及神经阻滞无额外获益

No Benefits of Adding Dexmedetomidine, Ketamine, Dexamethasone, and Nerve Blocks to an Established Multimodal Analgesic Regimen after Total Knee Arthroplasty.
PubMed 文献 · Anesthesiology · 2022-01-01

这项双盲随机对照试验纳入78例择期全膝关节置换术患者,比较标准多模式镇痛方案与额外增加五种干预(腘动脉与后膝关节囊间局部麻醉浸润、术中静脉右美托咪定和氯胺酮、术后追加地塞米松及两次收肌管阻滞)的效果。结果显示两组24小时累计阿片类药物消耗无显著差异(研究组23.7±18.0 mg vs 对照组29.3±18.7 mg,P=0.189),疼痛评分、恢复质量及功能结局亦无重要差异,但研究组低血压事件更常见(64.1% vs 33.3%,P=0.010)。

要点

  • 在已有椎管内吗啡、关节周围浸润、单次收肌管阻滞和地塞米松的基础上,追加五种干预未减少阿片消耗。
  • 追加干预未改善疼痛评分、恢复质量或功能结局。
  • 追加干预组低血压发生率显著更高(64.1% vs 33.3%,P=0.010)。

核心结论

  • 在已有周围局部麻醉浸润、椎管内吗啡、单次收肌管阻滞和地塞米松的多模式镇痛方案基础上,追加五种干预未能进一步减少全膝关节置换术后的阿片类药物消耗、疼痛评分或改善功能结局。

研究设计与样本

  • 双盲随机对照试验,纳入78例择期全膝关节置换术患者,随机分为对照组(n=39)和研究组(n=39)。

主要发现

  • 24小时累计阿片类药物消耗(口服吗啡当量)研究组为23.7±18.0 mg,对照组为29.3±18.7 mg,平均差异为-5.6 mg(95%CI -2.7 to 13.9),P=0.189,组间无差异。
  • 术后其他时间点阿片消耗、疼痛评分、恢复质量及达到康复里程碑的时间均无重要差异。
  • 研究组低血压事件发生率显著高于对照组(25/39 [64.1%] vs 13/39 [33.3%],P=0.010)。

临床怎么用

  • 对于接受椎管内吗啡、关节周围局部麻醉浸润、单次收肌管阻滞和地塞米松的全膝关节置换术患者,不建议常规追加腘动脉与后膝关节囊间局部麻醉浸润、静脉右美托咪定、静脉氯胺酮、额外地塞米松或重复收肌管阻滞。
  • 需注意追加上述干预可能增加低血压风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: An optimal opioid-sparing multimodal analgesic regimen to treat severe pain can enhance recovery after total knee arthroplasty. The hypothesis was that adding five recently described intravenous and regional interventions to multimodal analgesic regimen can further reduce opioid consumption. METHODS: In a double-blinded fashion, 78 patients undergoing elective total knee arthroplasty were randomized to either (1) a control group (n = 39) that received spinal anesthesia with intrathecal morphine, periarticular local anesthesia infiltration, intravenous dexamethasone, and a single injection adductor canal block or (2) a study group (n = 39) that received the same set of analgesic treatments plus five additional interventions: local anesthetic infiltration between the popliteal artery and capsule of the posterior knee, intraoperative intravenous dexmedetomidine and ketamine, and postoperatively, one additional intravenous dexamethasone bolus and two additional adductor canal block injections. The primary outcome measure was 24-h cumulative opioid consumption after surgery and secondary outcomes were other analgesics, patient recovery, functional outcomes, and adverse events. RESULTS: Opioid consumption was not different between groups at 24 h (oral morphine equivalents, mean ± SD; study: 23.7 ± 18.0 mg vs. control: 29.3 ± 18.7 mg; mean difference [95% CI], -5.6 mg [-2.7 to 13.9]; P = 0.189) and all other time points after surgery. There were no major differences in pain scores, quality of recovery, or time to reach rehabilitation milestones. Hypotensive episodes occurred more frequently in the study group (25 of 39 [64.1%] vs. 13 of 39 [33.3%]; P = 0.010). CONCLUSIONS: In the presence of periarticular local anesthesia infiltration, intrathecal morphine, single-shot adductor canal block and dexamethasone, the addition of five analgesic interventions-local anesthetic infiltration between the popliteal artery and capsule of the posterior knee, intravenous dexmedetomidine, intravenous ketamine, an additional intravenous dexamethasone dose, and repeated adductor canal block injections-failed to further reduce opioid consumption or pain scores or to improve functional outcomes after total knee arthroplasty.

来源:Anesthesiology,查看原文。版权归原作者所有。

引用

  1. Muñoz-Leyva F, Jack JM, Bhatia A, et al. No Benefits of Adding Dexmedetomidine, Ketamine, Dexamethasone, and Nerve Blocks to an Established Multimodal Analgesic Regimen after Total Knee Arthroplasty. Anesthesiology. 2022. PMID: 35867857. doi:10.1097/ALN.0000000000004326

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。